Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis

Respirology. 2019 Jan;24(1):55-62. doi: 10.1111/resp.13387. Epub 2018 Aug 23.

Abstract

Background and objective: Combined pulmonary fibrosis and emphysema (CPFE) is characterized by preserved lung volume and slower lung function decline. However, it is unclear at what extent emphysema begins to impact respiratory physiology and prognostic characteristics in idiopathic pulmonary fibrosis (IPF). We estimated the extent of emphysema that could be used to define CPFE in IPF.

Methods: The extent of emphysema was observed on high-resolution computed tomography scans and measured by a texture-based automated quantification system in 209 IPF patients. We analysed the impact of differences in the extent of emphysema on the annual decline rate and prognostic significance of lung function parameters.

Results: The extent of emphysema was ≥5% in 53 patients (25%), ≥10% in 23 patients (11%) and ≥15% in 12 patients (6%). Patients with emphysema to an extent of ≥5% were more frequently men and ever-smokers; they had more preserved lung volume and lower forced vital capacity (FVC) decline rates than those with no or trivial emphysema. The FVC decline rate was a significant predictor of mortality in patients with no or trivial emphysema (hazard ratio (HR): 0.933, P < 0.001) and in patients with an extent of emphysema ≥5% (HR: 0.906, P < 0.001). However, diffusing capacity of the lung for carbon monoxide (DLCO ) was the most significant prognostic factor in those patients with an extent of emphysema ≥10% (HR: 0.972, P = 0.040) and ≥15% (HR: 0.942, P = 0.023). A 10% cut-off value for the extent of emphysema created the most significant difference in the annual FVC decline rate in IPF patients.

Conclusion: In IPF, emphysema to an extent of ≥10% affects both the annual decline rate and the prognostic significance of FVC. This extent could be used to define CPFE.

Keywords: automated quantification system; combined pulmonary fibrosis and emphysema; idiopathic pulmonary fibrosis; pulmonary emphysema; pulmonary function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Computing Methodologies
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis* / complications
  • Idiopathic Pulmonary Fibrosis* / diagnosis
  • Idiopathic Pulmonary Fibrosis* / physiopathology
  • Lung* / diagnostic imaging
  • Lung* / physiopathology
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Pulmonary Emphysema* / diagnosis
  • Pulmonary Emphysema* / etiology
  • Pulmonary Emphysema* / physiopathology
  • Respiratory Function Tests / methods
  • Tomography, X-Ray Computed / methods
  • Vital Capacity